Início » Detalhes
Capa:

Vincristine-related neuropathy versus acute inflammatory demyelinating polyradiculoneuropathy in children with acute lymphoblastic leukemia

Autor(es)Brigo Francesco,Balter Rita,Marradi Pierluigi,Ferlisi Monica,Zaccaron Ada,Fiaschi Antonio,Frasson Emma,Bertolasi Laura
ResumoThe objective of this study was to evaluate whether electroneurography could help in differentiating between vincristine-induced neuropathy and acute inflammatory demyelinating polyradiculoneuropathy. We performed electroneurography in 7 children from September 2006 to March 2009 admitted to receive chemotherapy including vincristine for acute lymphoblastic leukemia, in whom severe acute limb weakness developed, suggesting vincristine-induced neuropathy. Three of 7 patients had electroneurography, suggesting acute inflammatory demyelinating polyradiculoneuropathy. They received intravenous immunoglobulins without discontinuing chemotherapy, and within 10 days their electroclinical conditions improved. Although electroneurography showed only absent F waves, preventing us from reaching a definitive neurophysiological diagnosis of acute inflammatory demyelinating polyradiculoneuropathy, children's presenting clinical manifestations, their disease course, and rapid and complete recovery after intravenous immunoglobulins argued strongly in its favor. A prompt, correct differential diagnosis of vincristine neuropathy and acute inflammatory demyelinating polyradiculoneuropathy in patients with acute lymphoblastic leukemia receiving vincristine is essential to improve disease outcome and prolong life expectancy.
Palavras-ChaveAcute inflammatory demyelinating polyradiculoneuropathy; Acute lymphoblastic leukemia; Electroneurography; Chemotherapy; Intravenous immunoglobulin; Neurophysiological studies; Vincristine-induced neuropathy
ImprentaJournal of Child Neurology, v. 27, n. 7, p. 867-874, 2012
Identificador do Objeto Digital10.1177/0883073811428379
DescritoresGuillain-Barre Syndrome - Cell ; Guillain-Barre Syndrome - Pathogenesis ; Guillain-Barre Syndrome - Proteins ; Guillain-Barre Syndrome - Public health
Data de Publicação:2012